Conduct of pharmacovigilance for medicines used by the paediatric population

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CHMP/235910/05
Effective from26/01/2007
KeywordsPharmacovigilance, safety, paediatrics, children, neonates, adverse drug reaction (ADR), periodic safety update report (PSUR), risk management plan (RMP), signal detection, patient information leaflet
DescriptionThis document provides guidance on the conduct of pharmacovigilance for medicines used by paediatric population. It applies to 'off-label' and unlicensed as well as licensed use.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/01/2010–present

Published: 27/06/2007

Published: 27/07/2005

Published: 17/10/2002

Related content

How useful was this page?

Add your rating